ADC Therapeutics ADCT
NYSE ADCT
$1.52 -0.08 (-4.63%)
As of: Nov 12, 2026 · 9:31 AM EST

ADC Therapeutics (ADCT) Return on Invested Capital [ROIC] (2020 - 2023)

Updated

ADC Therapeutics (ADCT) recorded Return on Invested Capital [ROIC] of -75.95% in Q3 2023, down 1.04 percentage points from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Return on Invested Capital [ROIC] (2020 - 2023) Analysis & Trends

Starting with Q2 2021, ADC Therapeutics' Return on Invested Capital [ROIC] history includes 6 quarters.

  • The Q3 2023 figure is the lowest quarterly Return on Invested Capital [ROIC] since Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 ADC Therapeutics 192.88 Mn -707.77 Mn 19.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -202.06%
Sep 30, 2023 -69.22%
Jun 30, 2023 -42.38%
Mar 31, 2023 -46.05%
Dec 31, 2022 -36.76%
Sep 30, 2022 -64.38%
Jun 30, 2022 -98.15%
Mar 31, 2022 -91.58%
Dec 31, 2021 -99.23%
Sep 30, 2021 -90.13%
Jun 30, 2021 -80.81%
Mar 31, 2021 -69.19%
Dec 31, 2020 -55.76%
Sep 30, 2020 -54.90%
API Access

ADC Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ADCT&period=max&api_key=YOUR_API_KEY